Early PSA test may allow middle-aged men to be risk-stratified

Sartor, Oliver
April 2008
Hem/Onc Today;4/25/2008, Vol. 9 Issue 7, p37
The article provides information on the results of a study on early prostate specific antigen (PSA) test. The study shows that a single PSA test in patients aged 50 years or younger may predict advanced prostate cancer diagnosed up to 25 years later. An overview of the study conducted by researchers at Memorial Sloan-Kettering Cancer Center and Lund University and is offered.


Related Articles

  • PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis. Salagierski, Maciej; Schalken, Jack A. // Cancers;2010, Vol. 2 Issue 3, p1432 

    The search for the biomarkers to precisely and non-invasively characterize the biology of prostate cancer (PCa) is the focus of many laboratories across the world. Although prostate-specific antigen (PSA) remains the standard diagnostic tool for PCa, its low specificity leads to unnecessary...

  • Dutasteride shown to reduce prostate Ca in high-risk men. Kuznar, Wayne // Urology Times;6/1/2009, Vol. 37 Issue 7, p1 

    The article reports on the Dutasteride (Avodart) which reduces the risk of biopsy-detectable prostate cancer for high-risk men in Chicago, Illinois. It reduces the risk for one-fourth in men high risk of disease without increasing the risk of high grade cancer. On other hand, 5-alpha-reductase...

  • Risks of PSA Screening Now Better Understood. Peres, Judy // JNCI: Journal of the National Cancer Institute;Nov2013, Vol. 105 Issue 21, p1590 

    The article focuses on the risk of prostate-specific antigen (PSA) testing. Peter Scardino, Managing Director of Memorial Sloan Kettering Cancer Center in New York, observes that to reduce the potential harm of prostate cancer screening, doctors should adopt a smarter approach like recommending...

  • The Influence of Statin Medications on Prostate-specific Antigen Levels. Hamilton, Robert J.; Goldberg, Kenneth C.; Platz, Elizabeth A.; Freedland, Stephen J. // JNCI: Journal of the National Cancer Institute;11/5/2008, Vol. 100 Issue 21, p1511 

    Background Recent data suggest that statin use may be associated with a reduced risk of advanced prostate cancer. However, the influence of statins on prostate-specific antigen (PSA) levels and what effect this could potentially have on prostate cancer diagnosis are unknown. Methods We conducted...

  • Study exposes PSA policy as haphazard.  // Pulse;4/9/2005, Vol. 65 Issue 14, p7 

    Reports on the causes of haphazard policy on prostate-specific antigen (PSA) testing in a wide variation between PCT in the number of men diagnosed and treated for prostate cancer. Findings in striking differences in prostate cancer diagnoses between neighboring PCT; Comment from Julia Verne,...

  • Prostate Specific Antigen is an Effective Marker for Prostate Cancer: Part I. Catalona, William J.; Loeb, Stacy // AUANews;Jan2007, Vol. 12 Issue 1, p10 

    The article discusses the effectiveness of prostate specific antigen (PSA) which is used as a marker for prostate cancer. It summarizes the evidence for PSA effectiveness, the correlation between prostate cancer risk and aggressiveness, the importance of using PSA as a continuous variable and it...

  • Using Predictive Value, Sensitivity and Specificity to Interpret Laboratory Tests: PSA for the Diagnosis of Prostate Cancer. Ashley, Thomas // Journal of Insurance Medicine;2005, Vol. 37 Issue 4, p261 

    The Prostate Cancer Prevention Trial yields a means to evaluate PSA screening for prostate cancer detection. The receiver operating characteristic curve shows that PSA above 2.5 provides optimum sensitivity and specificity for prostate cancer diagnosis by needle biopsy. However, the maximum...

  • Hair-loss drug confounds accuracy of PSA detection.  // Urology Times;Jan2007, Vol. 35 Issue 1, p4 

    The article reports on the effect of finasteride on the detection of prostate specific antigen (PSA). Based on a study from Brigham and Women's Hospital in Boston, Massachusetts, it was found that this hair loss drug caused PSA readings to be confusing. For men taking finasteride, the PSA level...

  • Feasibility of familial PSA screening: psychosocial issues and screening adherence. Sweetman, J.; Watson, M.; Norman, A.; Bunstead, Z.; Hopwood, P.; Melia, J.; Moss, S.; Eeles, R.; Dearnaley, D.; Moynihan, C. // British Journal of Cancer;2/27/2006, Vol. 94 Issue 4, p507 

    This study examined factors that predict psychological morbidity and screening adherence in first-degree relatives (FDRs) taking part in a familial PSA screening study. Prostate cancer patients (index cases - ICs) who gave consent for their FDRs to be contacted for a familial PSA screening study...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics